atai Life Sciences is a biopharmaceutical company dedicated to developing novel treatments for mental health disorders, allowing individuals worldwide to experience more fulfilling lives. The company is engaged in the creation of both psychedelic and non-psychedelic compounds alongside cutting-edge digital therapeutic tools. Atai's mission stems from a commitment to advancing mental health care through innovative solutions that drive meaningful behavioral change for patients. With headquarters in Berlin, New York City, and San Diego, atai promotes an inclusive and collaborative work environment that values diverse perspectives and teamwork. The company's guiding principles, which include Conscious Care, Bold Entrepreneurship, Collaborative Innovation, and Radical Responsibility, foster a culture of empowerment and continuous learning, ensuring that employees are aligned with the vision of revolutionizing mental health treatment.